Trial Profile
A randomized, therapy controlled, double blind, single center cross-over pilot study to evaluate the antihypertensive and pleiotropic effects of telmisartan in comparison to amlodipin on myocardial diastolic function , vascular function and carbohydrate metabolism in 30 patients with metabolic syndrome, mild to moderate hypertension and without overt coronary artery disease
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Jun 2011
Price :
$35
*
At a glance
- Drugs Telmisartan (Primary) ; Amlodipine
- Indications Heart failure; Hypertension
- Focus Pharmacodynamics
- Acronyms telmipleio
- 10 Jun 2011 New trial record